Consainsights logo

Biosimilar Testing And Development Services Market Size, Share, Industry Trends and Forecast to 2030

Biosimilar Testing And Development Services Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Biosimilar Testing And Development Services Market

Market Size & CAGR of Biosimilar Testing And Development Services market in 2021

The global biosimilar testing and development services market had a market size of USD 3.5 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 8.3% from 2021 to 2028, reaching a market size of USD 6.2 billion by the end of the forecast period.

COVID-19 Impact on the Biosimilar Testing And Development Services Market

The COVID-19 pandemic had a mixed impact on the biosimilar testing and development services market. While the initial disruption in supply chains and clinical trials affected the market, the increased focus on healthcare and biotechnology research led to a surge in demand for biosimilar testing and development services. The market witnessed a temporary slowdown in 2020 but rebounded quickly in 2021.

Biosimilar Testing And Development Services Dynamics

The biosimilar testing and development services market is driven by factors such as the growing prevalence of chronic diseases, increasing demand for cost-effective treatment options, and the need for personalized medicine. Key players in the market are focusing on expanding their service offerings, enhancing research and development capabilities, and forming strategic partnerships to gain a competitive edge.

Segments and Related Analysis

By Service Type

The biosimilar testing and development services market can be segmented by service type into biosimilar analytical testing, clinical research services, and consulting services. Each segment plays a vital role in the biosimilar development process, ensuring quality, safety, and efficacy of biosimilar products.

By Application

The market can also be segmented by application into oncology, autoimmune diseases, infectious diseases, and others. The increasing prevalence of oncological and autoimmune diseases is driving the demand for biosimilar testing and development services in these therapeutic areas.

By Region Analysis

The biosimilar testing and development services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America currently holds the largest market share due to the presence of key market players, advanced healthcare infrastructure, and favorable regulatory environment. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing investments in biotechnology research and healthcare.

Key Market Players and Competitive Landscape

Some of the key players in the biosimilar testing and development services market include Thermo Fisher Scientific Inc., Eurofins Scientific, Charles River Laboratories, ICON plc, SGS SA, and Covance Inc. These players are actively engaged in expanding their service portfolio, investing in research and development, and exploring strategic collaborations to strengthen their market position.

Recent Happenings in the Biosimilar Testing And Development Services Market

In recent years, the biosimilar testing and development services market has witnessed several noteworthy developments. Key players have announced new service offerings, strategic acquisitions, and partnerships to enhance their capabilities and cater to the evolving needs of the healthcare industry. These developments indicate a growing focus on innovation and collaboration within the market.

Biosimilar Testing and Development Services Market FAQs